Entacapone Market Size & Growth Analysis Report, 2021-2027

The global entacapone market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Entacapone is used by combining with levodopa/carbidopa for the treatment of the end-of-dose "wearing-off" effect in patients with Parkinson's disease. Parkinson's disease is a disorder of the central nervous. It is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. The major factor for the growth of the market is the increasing prevalence of Parkinson disease.

According to the Parkinson Foundation, almost one million people are living with Parkinson disease in the US which is expected to rise to 1.2 million in 2030. Additionally, approximately 60,000 Americans are diagnosed with PD each year and more than 10 million people are living with PD globally. Further, PD disease increases with age however, an estimated 4% of people with PD are diagnosed before age 50. Moreover, the prevalence of PD in men are 1.5 times as compared to women. However, increasing cost for the treatment of PD is hampering the growth of the global entacapone market during the forecast period.

To Request a Sample of our Report on Entacapone Market: https://www.omrglobal.com/request-sample/entacapone-market

Some major key players in the market include Novartis International AG, Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2021, STADA declared European launch of the Lecigon triple-combination of levodopa, carbidopa, and entacapone for treating advanced Parkinson's disease.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered-

· By Product

· By Application

• Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

• Competitive Landscape-Novartis International AG, Teva Pharmaceutical Industries Ltd.,and Sun Pharmaceutical Industries Ltd., among others.

(Get 15% Discount on Buying this Report)

A full Report of Entacapone Market is Available at: https://www.omrglobal.com/industry-reports/entacapone-market

Global Entacapone Market Report by Segment

By Product

• Purity:98%

• Purity: above 98%

By Application

• Tablet Product

• Capsule Product

• Others

Global Entacapone Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.